Cognitive Impairments Clinical Trial
Official title:
LDX in the Treatment of Executive Function Difficulties in Women After Oophorectomy
This is a double-blind, placebo-controlled, study testing whether LDX improves cognitive function and EF in 20 postmenopausal women who report onset of cognitive difficulties after oophorectomy (with or without subsequent chemo/adjunctive therapy). Brain imaging is included at critical time points to obtain objective data regarding effects of LDX as well as potential predictors of resilience in the face of oophorectomy.
Participants will be asked to undergo three brain-imaging scans throughout the course of the study. Once they are deemed eligible for participation based on two assessment visits, they will be scheduled for their baseline test day. On this they, they will be asked to under a series of cognitive tests following by a brain-imaging scan. They will then take the first dose of either the LDX or placebo, wait for 3 hours and then undergo another brain-imaging scan to assess acute changes to memory/cognition due to the study drug. They will then come in for three 30-minute check-in visits during weeks 2, 4 and 6 on the study drug. They will be asked to undergo a final scan and series of cognitive tasks during weeks 8-10 on the study drug. They will then be discharged from active study participation. All participants, regardless of randomization, will be offered a consultation with the study MD and optional prescription for 4-weeks of treatment with LDX. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04470219 -
Digital Support for People With Cognitive Impairment
|
N/A | |
Completed |
NCT01071044 -
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
|
Phase 4 | |
Completed |
NCT02962687 -
Video-Enhanced Care Management for Medically Complex Veterans
|
N/A | |
Completed |
NCT01324024 -
Attention & Memory Impairments in Menopausal Women
|
Phase 4 | |
Recruiting |
NCT05053204 -
Influence Factors and Cognitive Characteristics in Unipolar and Bipolar Depression:Based on the THINC-it Tool
|
||
Recruiting |
NCT02778581 -
Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment
|
N/A | |
Suspended |
NCT00197483 -
Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia
|
Phase 2 | |
Completed |
NCT05585424 -
Effectiveness of a Program Based on Observation-action Training (AOT) in Patients With Cognitive Impairment.
|
N/A | |
Completed |
NCT05822596 -
Tablet-based Interactive Games in Elderly With Cognitive Impairment and Persons With Intellectual Disability
|
N/A | |
Completed |
NCT02830854 -
Molecular Hydrogen for Cognitive Function and Performance in Elderly
|
Phase 3 | |
Recruiting |
NCT01466205 -
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
|
Phase 2 | |
Recruiting |
NCT05896189 -
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
|
N/A | |
Not yet recruiting |
NCT06212726 -
RTL Concussion Communication
|
N/A | |
Completed |
NCT02868684 -
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
|
||
Recruiting |
NCT04490330 -
Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients
|
||
Completed |
NCT02677987 -
The "Light for the Brain" Study
|
N/A | |
Completed |
NCT02746484 -
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program
|
N/A |